Pardo, Benjamin

Publishing since 2001 (Junior)

Has published 17 publications in 9 years

Number of publications published per year by Pardo, Benjamin. (Source : PubMed)

Distribution of publications types for Pardo, Benjamin. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Martínez P, Bouza C, Hermida M, Fernández J, Toro MA, Vera M, Pardo B, Millán A, Fernández C, Vilas R, Viñas A, Sánchez L, Felip A, Piferrer F, Ferreiro I, Cabaleiro S. Identification of the major sex-determining region of turbot (Scophthalmus maximus).  Genetics  2009;183;4  
•  Majem M, Salazar R, Garcia M, Clopes A, Muñoz C, Pardo B, Martinez M, Cuadra C, Montes A, Mis R, Savulsky C, Ramon Germa-Lluch J. A phase I clinical and pharmacokinetic study (LIPOTEC - GP PHARM/DOXO 01) of a new liposomal doxorubicin given as 3-week schedule in patients with solid tumors.  J Liposome Res  2009  
•  Majem M, Salazar R, Garcia M, Clopes A, Muñoz C, Pardo B, Martinez M, Cuadra C, Montes A, Mis R, Savulsky C, Ramon Germa-Lluch J. A phase I clinical and pharmacokinetic study (LIPOTEC - GP PHARM/DOXO 01) of a new liposomal doxorubicin given as 3-week schedule in patients with solid tumors.  J Liposome Res  2009;19;4  
•  Izquierdo MA, Bowman A, García M, Jodrell D, Martinez M, Pardo B, Gómez J, López-Martin JA, Jimeno J, Germá JR, Smyth JF. Phase I clinical and pharmacokinetic study of plitidepsin as a 1-hour weekly intravenous infusion in patients with advanced solid tumors.  Clin. Cancer Res.  2008;14;10  
•  Pardo B, Paz-Ares L, Tabernero J, Ciruelos E, García M, Salazar R, López A, Blanco M, Nieto A, Jimeno J, Izquierdo MA, Trigo JM. Phase I clinical and pharmacokinetic study of kahalalide F administered weekly as a 1-hour infusion to patients with advanced solid tumors.  Clin. Cancer Res.  2008;14;4  
•  Gutiérrez A, Gámez R, Mas R, Noa M, Pardo B, Marrero G, Pérez Y, González R, Curveco D, García H. Oral subchronic toxicity of a lipid extract from Roystonea regia fruits in mice.  Drug Chem Toxicol  2008;31;2  
•  Bottani A, Chelly J, de Brouwer AP, Pardo B, Barker M, Capra V, Bartoloni L, Antonarakis SE, Conrad B. Sequence variation in ultraconserved and highly conserved elements does not cause X-linked mental retardation.  Am. J. Med. Genet. A  2007;143A;8  
•  Satrústegui J, Pardo B, Del Arco A. Mitochondrial transporters as novel targets for intracellular calcium signaling.  Physiol. Rev.  2007;87;1  
•  Honegger P, Pardo B. Aggregating brain cell cultures: investigation of stroke related brain damage.  ALTEX  2007;24 Spec No  
•  Bottani A, Pardo B, Bouchardy I, Schoumans J, Toutain A, Conrad B. No major contribution of the TGFBR1- and TGFBR2-mediated pathway to Kabuki syndrome.  Am. J. Med. Genet. A  2006;140;8  

[ See timeline ] [ See all publications ]